Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor Moshe C. OrnsteinLaura S. Wood Commentary Open access 26 May 2023 Pages: 3599 - 3609
A Podcast Discussion on the Current Treatment Landscape for Renal Cell Carcinoma Philipp IvanyiJonas Paul WiegmannViktor Grünwald Commentary Open access 12 July 2023 Pages: 3610 - 3619
First Line Medical Treatment of Metastatic Renal Cell Carcinoma: A Podcast on Choosing Wisely and Managing Safely Philipp IvanyiJonas Paul WiegmannViktor Grünwald Commentary Open access 12 July 2023 Pages: 3620 - 3625
Narrative Review of Topiramate: Clinical Uses and Pharmacological Considerations Nathan Z. PearlCaroline P. BabinAlan D. Kaye Review 27 June 2023 Pages: 3626 - 3638
Burden and Treatment of Achondroplasia: A Systematic Literature Review Molly C. MurtonEmma L. A. DraneThomas J. Butt Review Open access 29 June 2023 Pages: 3639 - 3680
Pharyngeal Reconstruction Methods to Reduce the Risk of Pharyngocutaneous Fistula After Primary Total Laryngectomy: A Scoping Review Alvaro SanabriaMaría Paula OliveraAlfio Ferlito Review Open access 12 July 2023 Pages: 3681 - 3696
Desmoid Tumors: A Comprehensive Review Meryem BektasTimothy BellAna B. Oton Review Open access 12 July 2023 Pages: 3697 - 3722
Factors Associated with Severe COVID-19 Among Patients with Rheumatoid Arthritis: A Large, Nationwide Electronic Health Record Cohort Study in the United States Yizhou YeXiaomeng YueSeoyoung C. Kim Original Research Open access 20 June 2023 Pages: 3723 - 3738
Model-Informed Support of Dose Selection for Prophylactic Treatment with Dalcinonacog Alfa in Adult and Paediatric Hemophilia B Patients Alan FarajNatacha Le MoanUlrika S. H. Simonsson Original Research Open access 21 June 2023 Pages: 3739 - 3750
Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective Gérard de PouvourvillePatrick RossignolJuan Jose Garcia Sanchez Original Research Open access 21 June 2023 Pages: 3751 - 3769
Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries Eva FundingGillian LoweCarly Rich Original Research Open access 23 June 2023 Pages: 3770 - 3783
Sugammadex Reduced the Incidence of Postoperative Pulmonary Complications in Susceptible Patients Identified by ARISCAT Risk Index: Systematic Review and Meta-analysis Yun-Xiao BaiJing-Jing HanQing-Ping Wu Original Research 23 June 2023 Pages: 3784 - 3803
Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study Min ZhengXiang ChenJie Zheng Original Research 25 June 2023 Pages: 3804 - 3816
Large-Scale, Multicenter, Prospective Registry Study of Ripretinib in Advanced GIST: A Real-World Study from China Xinhua ZhangPeng ZhangJian Li Original Research Open access 25 June 2023 Pages: 3817 - 3829
Analyses of Dupilumab-Related Ocular Adverse Drug Reactions Using the WHO’s VigiBase Eri HiraiTomoko HarukiDai Miyazaki Original Research 26 June 2023 Pages: 3830 - 3856
Impact of Pertuzumab and Ado-Trastuzumab Emtansine on Cumulative Avoidance of Recurrence Among Women Treated for Locally Advanced, Inflammatory, or Early-Stage Nonmetastatic HER2-Positive Breast Cancer in the United States Jesse A. SussellDavid J. PressAnita Fung Original Research Open access 26 June 2023 Pages: 3857 - 3874
Real-World Evaluation of the Management, Treatment Pathways and Outcome of Melanoma Patients with Target Therapies in Italy Ilaria Gioia MarconDiletta ValsecchiLuca Degli Esposti Original Research Open access 27 June 2023 Pages: 3875 - 3895
Matching-Adjusted Indirect Comparison Between Risankizumab and Ustekinumab for Induction and Maintenance Treatment of Moderately to Severely Active Crohn’s Disease Marla DubinskyChristopher MaTom O’Connell Original Research Open access 27 June 2023 Pages: 3896 - 3911
The Added Prognostic Value of Oncotype Recurrence Score to AJCC Prognostic Staging System in Stage III ER+/HER2− Breast Cancer Maoli WangMingdi ZhangHongliang Chen Original Research 29 June 2023 Pages: 3912 - 3925
The Relationship Between Signature Time and Functional Health Literacy: Results from a Prospective Study of an Urban Low-Income Population Receiving Long-Term Anticoagulation Ali AlobaidiConnie H. YanEdith A. Nutescu Original Research Open access 30 June 2023 Pages: 3926 - 3936
Efficacy and Safety of Pirfenidone in Advanced Versus Non-Advanced Idiopathic Pulmonary Fibrosis: Post-Hoc Analysis of Six Clinical Studies Jürgen BehrSteven D. NathanLisa Lancaster Original Research Open access 30 June 2023 Pages: 3937 - 3955
Factors That Predict a Sustained Humoral Response to COVID-19 Vaccines in Kidney Transplant Recipients Pierre PommerollePierre LaurentOphélie Fourdinier Original Research 01 July 2023 Pages: 3956 - 3970
Dose Nomogram of Individualization of the Initial Follicle-Stimulating Hormone Dosage for Patients with Polycystic Ovary Syndrome Undergoing IVF/ICSI with the GnRH-Ant Protocol: A Retrospective Cohort Study Manfei SiXinyu QiJie Qiao Original Research Open access 03 July 2023 Pages: 3971 - 3985
Botulinum Toxin Utilization, Treatment Patterns, and Healthcare Costs Among Patients with Spasticity or Cervical Dystonia in the US Michael HullVamshi Ruthwik AnupindiJonathan Bouchard Original Research Open access 07 July 2023 Pages: 3986 - 4003
Study on the Relationship Between Differentially Expressed Proteins in Breast Cancer and Lymph Node Metastasis Yu-Lu SunYi-Xin ZhaoYong-Zhong Yao Original Research 09 July 2023 Pages: 4004 - 4023
Application of Autologous Hair Transplantation Technique in Children with Cicatricial Alopecia Jiping WangJing LiuYanni Wang Original Research Open access 11 July 2023 Pages: 4024 - 4031
Neuroendocrine Component in Extrahepatic Cholangiocarcinoma is Associated with Better Survival: Data from the SEER Study Tian-Run LvFei LiuFu-Yu Li Original Research 11 July 2023 Pages: 4032 - 4041
Assessing the Effects of Changing Patterns of Inhaled Corticosteroid Dosing and Adherence with Fluticasone Furoate and Budesonide on Asthma Management Peter Daley-YatesDave SinghMaximilian Plank Original Research Open access 12 July 2023 Pages: 4042 - 4059
Societal Utilities for Cognitive Impairment in Schizophrenia: Developing a Preference-Based Scoring Algorithm Based on the Schizophrenia Cognition Rating Scale Irene SantiAndrew J. LloydMatthijs M. Versteegh Original Research Open access 13 July 2023 Pages: 4060 - 4073
Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study Masaru InataniYusuke OriiMasaki Tanito Original Research Open access 15 July 2023 Pages: 4074 - 4092
Characterizing Opioid Use Disorder Encounters in the Midwest Region, USA Yifei LiuSuman SahilHolly N. Hagle Brief Report 28 June 2023 Pages: 4093 - 4100
B-Clear Phase 2b Study Design: Establishing the Efficacy and Safety of Bepirovirsen in Patients with Chronic Hepatitis B Virus Infection Jennifer CremerRobert ElstonDickens Theodore Study Protocol Open access 01 July 2023 Pages: 4101 - 4110
Letter to the Editor Regarding “Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single Agent Pembrolizumab for High-Risk Early-Stage Triple Negative Breast Cancer in the United States” Steven Sorscher Letter 11 July 2023 Pages: 4111 - 4113
Correction to: A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19 Thomas BieberEugen FeistPeter C. Taylor Correction Open access 22 June 2023 Pages: 4114 - 4115
Correction to: Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor Moshe C. OrnsteinLaura S. Wood Correction Open access 13 July 2023 Pages: 4116 - 4116